Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Delirium in Elderly Orthopedic Surgery
NCT03629262Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of delirium within the first 5 days after surgery. Started Oct 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT03629262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03629262.